Wafik El-Deiry: Great research planning meeting with Dr. Benedito Carneiro
Wafik El-Deiry shared a post on LinkedIn:
“Great research planning meeting with Dr. Benedito A. Carneiro, the Director of Clinical Research and Cancer Drug Development (Phase 1) in Hematology/Oncology at The Warren Alpert Medical School of Brown University and Lifespan and Co-Leader of the Cancer Therapeutics Program at Legorreta Cancer Center at Brown University.
We have a number of exciting bench-to-bedside projects we’re collaborating on with El-Deiry lab members that are bringing forward novel therapeutic combinations and biomarker insights.”
Source: Wafik El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry made important contributions to cell death signaling and our understanding of the sensitivity of tumors to chemotherapy. El-Deiry has more than 400 peer-reviewed publications and 5 edited books.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023